Biopharmaceutical process development – Trends/ Challenges/Opportunities
13th September 2019 | 10:30AM GMT/ 3:00PM IST | Kumar Gaurav, AGM (Regulatory Affairs) at Panacea Biotec Ltd |BOOK FREE SEAT
- Current trends and regulation affecting Biopharmaceutical Industry
- Journey from Lab scale to Commercial –Overcoming Scalability design hurdles
- QbD-Bringing Improvements in Biologics development and Manufacturing Space
Presented by Kumar Gaurav, AGM (Regulatory Affairs) at Panacea Biotec Ltd
Kumar Gaurav is a seasoned professional with 15+ years of experience working in various capabilities in Drug Development and Regulatory Affairs functions in Vaccines and Biologics Industry.
He has played key leadership and strategic planning roles in development, scale up, technology transfer, devising regulatory strategies, operation and ensuring compliance. He comes with reliable knowledge base encompassing challenges, opportunities and unique requirements of the industry through various stages of product development from conceptualization, development strategy to scale-up, manufacturing operations, Quality compliance, Regulatory submissions extending further to commercialization, product registration and incremental innovation of marketed products including risk management at each stage.
He is creative problem solver and team player who thrive in diverse work environment. He exhibits well-developed and demonstrable executive leadership skills and strong background in product management with an extensive line-management experience along with a proven track record of significant achievements many of which are now a major part of the company’s vaccine portfolio and several others which are under various stages of Pre-clinical and Clinical trials gearing up for market launch.